Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT06988059) titled 'A Study of CT0596 in Plasma Cell Leukemia' on May 16.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Condition:
Plasma Cell Leukemia
Intervention:
Drug: CAR-T cells Infusion chimeric antigen receptor T cells
Recruitment Status: Not recruiting
Phase: Early Phase 1
Date of First Enrollment: May 26, 2025
Target Sample Size: 27
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/ct2/show/NCT069880...